Difficulty: Medium
Average Score: 90%
Practice
A patient with a history of breast cancer is prescribed tamoxifen (Nolvadex). What critical information should the nurse include in the patient education?
Correct answer
A
Rationale
In the context of pharmacology and patient education, the critical information that the nurse should include for a patient prescribed tamoxifen (Nolvadex) is option A: "Tamoxifen may increase the risk of venous thromboembolism, so patients should be educated about the signs and symptoms of blood clots."
This information is crucial because tamoxifen, as a selective estrogen receptor modulator, can indeed increase the risk of venous thromboembolism due to its estrogen-like effects on the body. Patients need to be aware of the signs and symptoms of blood clots, such as swelling, redness, warmth, or pain in the extremities, chest pain, shortness of breath, and coughing up blood, as early detection and intervention are key in preventing serious complications.
The other options are incorrect:
B) Weight gain as a side effect of tamoxifen is possible, but it is not as critical or potentially life-threatening as venous thromboembolism.
C) While tamoxifen may have a protective effect on bone density, it is not the most critical piece of information to prioritize in patient education compared to the risk of venous thromboembolism.
D) Hot flashes and menopausal symptoms are common side effects of tamoxifen but are not as urgent as educating the patient about the risk of venous thromboembolism.
In an educational context, emphasizing the most critical and potentially life-threatening side effects of medications is paramount to ensure patient safety and adherence to the prescribed treatment plan. Patient education plays a vital role in empowering individuals to monitor their health, recognize warning signs, and seek timely medical attention when needed.
This information is crucial because tamoxifen, as a selective estrogen receptor modulator, can indeed increase the risk of venous thromboembolism due to its estrogen-like effects on the body. Patients need to be aware of the signs and symptoms of blood clots, such as swelling, redness, warmth, or pain in the extremities, chest pain, shortness of breath, and coughing up blood, as early detection and intervention are key in preventing serious complications.
The other options are incorrect:
B) Weight gain as a side effect of tamoxifen is possible, but it is not as critical or potentially life-threatening as venous thromboembolism.
C) While tamoxifen may have a protective effect on bone density, it is not the most critical piece of information to prioritize in patient education compared to the risk of venous thromboembolism.
D) Hot flashes and menopausal symptoms are common side effects of tamoxifen but are not as urgent as educating the patient about the risk of venous thromboembolism.
In an educational context, emphasizing the most critical and potentially life-threatening side effects of medications is paramount to ensure patient safety and adherence to the prescribed treatment plan. Patient education plays a vital role in empowering individuals to monitor their health, recognize warning signs, and seek timely medical attention when needed.